Kevin M. Ban - Nov 18, 2022 Form 4 Insider Report for Walgreens Boots Alliance, Inc. (WBA)

Role
EVP, Chief Medical Officer
Signature
/s/ Kevin M. Ban by Cherita Thomas, Attorney-in-Fact
Stock symbol
WBA
Transactions as of
Nov 18, 2022
Transactions value $
-$63,394
Form type
4
Date filed
11/22/2022, 07:20 PM
Previous filing
Nov 3, 2022
Next filing
Oct 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WBA Common Stock Options Exercise $351K +10.3K +36.91% $34.04 38.2K Nov 18, 2022 Direct F1
transaction WBA Common Stock Sale -$414K -10.3K -26.96% $40.19 27.9K Nov 18, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WBA Employee Stock Option (Right to Buy) Options Exercise $0 -10.3K -66.6% $0.00 5.17K Nov 18, 2022 Common Stock 10.3K $34.04 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares underlying restricted stock units issued in lieu of dividends (through November 15, 2022) on outstanding restricted stock units.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.19 to $40.22, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated.
F3 The option, representing a right to purchase a total of 15,470 shares, became exercisable with respect to 5,151 shares on November 1, 2021, and with respect to 5,152 shares on November 1, 2022.